Bharat Biotech unveils world’s first intranasal COVID-19 vaccine ‘iNCOVACC’

iNCOVACC is a cost-effective vaccine that utilizes a vector-based platform, which can be easily updated with emerging variants leading to large-scale production.

Vikal Samdariya

This post is for paying subscribers only

SUBSCRIBE NOW

Already have an account? Login